ConductScience.org, home

Trial · NCT01157351

Results by group26

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Time to First Treatment FailurePaliperidone Palmitate41695% Confidence Interval 285 to NADays
Time to First Treatment FailureOral Antipsychotics22695% Confidence Interval 147 to 304Days
Time to First Psychiatric Hospitalization or Arrest/IncarcerationPaliperidone PalmitateNA95% Confidence Interval NA to NADays
Time to First Psychiatric Hospitalization or Arrest/IncarcerationOral Antipsychotics27495% Confidence Interval 202 to 407Days
Change From Baseline in Personal and Social Performance (PSP) Total Score During Overall Treatment DurationPaliperidone Palmitate5.75Standard Error 0.690Units on a scale
Change From Baseline in Personal and Social Performance (PSP) Total Score During Overall Treatment DurationOral Antipsychotics5.36Standard Error 0.690Units on a scale
Time to First Psychiatric HospitalizationPaliperidone PalmitateNA95% Confidence Interval NA to NADays
Time to First Psychiatric HospitalizationOral AntipsychoticsNA95% Confidence Interval NA to NADays
Change From Baseline in Clinical Global Impression - Severity (CGI-S) Score During Overall Treatment DurationPaliperidone Palmitate-0.48Standard Error 0.038Units on a scale
Change From Baseline in Clinical Global Impression - Severity (CGI-S) Score During Overall Treatment DurationOral Antipsychotics-0.43Standard Error 0.037Units on a scale
Percentage of Participants in Each Event Category of First Treatment FailurePaliperidone PalmitateTreatment Failure Due to Any Event39.8percentage of participants
Percentage of Participants in Each Event Category of First Treatment FailureOral AntipsychoticsTreatment Failure Due to Any Event53.7percentage of participants
Percentage of Participants in Each Event Category of First Treatment FailurePaliperidone PalmitateArrest/incarceration21.2percentage of participants
Percentage of Participants in Each Event Category of First Treatment FailureOral AntipsychoticsArrest/incarceration29.4percentage of participants
Percentage of Participants in Each Event Category of First Treatment FailurePaliperidone PalmitatePsychiatric hospitalization8.0percentage of participants
Percentage of Participants in Each Event Category of First Treatment FailureOral AntipsychoticsPsychiatric hospitalization11.9percentage of participants
Percentage of Participants in Each Event Category of First Treatment FailurePaliperidone PalmitateD/C due to safety/tolerability6.6percentage of participants
Percentage of Participants in Each Event Category of First Treatment FailureOral AntipsychoticsD/C due to safety/tolerability3.7percentage of participants
Percentage of Participants in Each Event Category of First Treatment FailurePaliperidone PalmitateTreatment supplementation2.2percentage of participants
Percentage of Participants in Each Event Category of First Treatment FailureOral AntipsychoticsTreatment supplementation2.8percentage of participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01157351/results